PATRYCJA SALACHNA tenders – contracts won
Public contracts won and contractor statistics
- Lots won
- 1
- Win rate
- 100%
- Value won
- 597 851 zł
- Buyers
- 1
Most often wins with
Value won and average competition available in Mimira Market Analysis.
| Buyer | Lots won | Value won | Avg. competition | Win rate |
|---|---|---|---|---|
![]() | 1 |
Recent tenders won by PATRYCJA SALACHNA
| Tender subject | Buyer | Value | Award date |
|---|---|---|---|
| Polska – Ogólne usługi lekarskie – świadczenia zdrowotne udzielane przez lekarzy w zakresie anestezjologii i intensywnej terapii 2024-AIT-1Mazowieckie | Beskidzkie Centrum Onkologii - Szpital Miejski Im. J. Pawła Ii W Bielsku -Białej | — | |
See the full Market Analysis data Full award history, bid values, competition and contractor performance – in Mimira Market Analysis. | |||
Frequently asked questions
Public procurement summary for PATRYCJA SALACHNA
How many tenders has PATRYCJA SALACHNA won?
PATRYCJA SALACHNA has won 1 contract lots in public procurement worth an estimated 597 851 zł in total. The company's bids were chosen by 1 different buyers, with a win rate of 100% across the tenders it took part in.
What is the largest contract won by PATRYCJA SALACHNA?
The highest value among PATRYCJA SALACHNA's recently awarded contracts is 597 851 zł – a contract awarded by Beskidzkie Centrum Onkologii - Szpital Miejski Im. J. Pawła Ii W Bielsku -Białej.
Which buyers does PATRYCJA SALACHNA work with most often?
The institutions that most often choose PATRYCJA SALACHNA's bids include Beskidzkie Centrum Onkologii - Szpital Miejski Im. J. Pawła Ii W Bielsku -Białej. See their profiles to check who else competes for these contracts.
In which regions does PATRYCJA SALACHNA win tenders?
Most of PATRYCJA SALACHNA's recent awards are in the province of Mazowieckie.
Where to find data on tenders won by PATRYCJA SALACHNA?
The data comes from contract award notices published in BZP and TED. The full award history, bid values and competition analysis for PATRYCJA SALACHNA are available in Mimira Market Analysis.
